Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06116630 · ClinicalTrials.gov registry record

StrokeCog-BBB to Study Cognitive Outcomes Following Stroke

A clinical trial of Stroke, sponsored by Stanford University.

Recruiting
Registry status
350
Enrollment target
1
Study location

NCT06116630: Recruiting study of Stroke, sponsored by Stanford University.

NCT06116630 is a study of Stroke that is actively recruiting participants, run by Stanford University. The registered enrollment target is 350 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06116630, a study of Stroke, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
350 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study is to learn about cognitive outcomes in stroke patients. The main question it aims to answer are: 1. Is blood-brain barrier permeability compromised for years after stroke, 2. Is a blood biomarker of imbalanced angiogenesis dysregulated in chronic stroke and 3. Are there biomarkers that separately or together predicts cognitive decline after stroke, and are other MRI, blood, and clinical characteristics that are associated. Participants will undergo cognitive testing and MRIs two years apart. Researchers will compare cognitive outcomes in non-stroke patients who have cardiovascular risk factors to understand the effects of stroke on these outcomes.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST DCE-MRI

Study Locations (1)

California

  • Stanford University Hospital - Palo Alto

Trial Details

FieldValue
Enrollment Target 350 participants
Start Date 2022-05-17
Est. Completion 2027-12-31

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT06116630

The ClinicalTrials.gov registry entry for NCT06116630 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (97% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which DCE-MRI is the first listed.

NCT06116630 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06116630 about?

NCT06116630 is a clinical study titled "StrokeCog-BBB to Study Cognitive Outcomes Following Stroke". The goal of this observational study is to learn about cognitive outcomes in stroke patients. The main question it aims to answer are: 1. Is blood-brain barrier permeability compromised for years after stroke, 2. Is a blood biomarker of imbalanced angiogenesis dysregulated in chronic stroke and 3. A...

What is the current status of trial NCT06116630?

This trial is currently recruiting. The enrollment target is 350 participants. The study started on 2022-05-17. Estimated completion is 2027-12-31.

What conditions does trial NCT06116630 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT06116630?

The interventions under investigation include: DCE-MRI (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06116630?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06116630 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.